NYSE:PRLBProto Labs Stock Price, Forecast & News

Proto Labs' stock was trading at $78.36 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PRLB shares have increased by 66.1% and is now trading at $130.13.
View which stocks have been most impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Proto Labs in the last year. There are currently 5 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Proto Labs.

Proto Labs is scheduled to release its next quarterly earnings announcement on Thursday, October 22nd 2020.
View our earnings forecast for Proto Labs.

Proto Labs Inc (NYSE:PRLB) announced its quarterly earnings results on Tuesday, July, 28th. The industrial products company reported $0.59 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.36 by $0.23. The industrial products company had revenue of $106.60 million for the quarter, compared to analyst estimates of $100.46 million. Proto Labs had a net margin of 12.99% and a return on equity of 10.02%. The business's quarterly revenue was down 8.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.71 EPS.
View Proto Labs' earnings history.

6 analysts have issued 12-month target prices for Proto Labs' shares. Their forecasts range from $69.00 to $145.00. On average, they anticipate Proto Labs' stock price to reach $98.00 in the next year. This suggests that the stock has a possible downside of 24.7%.
View analysts' price targets for Proto Labs.

Media stories about PRLB stock have trended positive recently, InfoTrie reports. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Proto Labs earned a news sentiment score of 2.1 on InfoTrie's scale. They also assigned media headlines about the industrial products company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days.
View the latest news about Proto Labs.

Proto Labs saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 4,490,000 shares, an increase of 7.4% from the June 15th total of 4,180,000 shares. Based on an average daily trading volume, of 286,900 shares, the days-to-cover ratio is currently 15.7 days. Currently, 17.9% of the shares of the stock are sold short.
View Proto Labs' Current Options Chain.

Some companies that are related to Proto Labs include Illinois Tool Works (ITW), Parker-Hannifin (PH), Stanley Black & Decker (SWK), Dover (DOV), Ingersoll-Rand (IR), Xylem (XYL), IDEX (IEX), Nordson (NDSN), Graco (GGG), Snap-on (SNA), Pentair (PNR), Gardner Denver (GDI), Donaldson (DCI), Middleby (MIDD) and Lincoln Electric (LECO).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Proto Labs investors own include Brainstorm Cell Therapeutics (BCLI), Netflix (NFLX), Tesla (TSLA), NVIDIA (NVDA), Starbucks (SBUX), Walt Disney (DIS), Gilead Sciences (GILD), Intel (INTC), Baidu (BIDU) and Alphabet (GOOG).

Proto Labs trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRLB."

Proto Labs' stock is owned by many different retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (5.73%), Sumitomo Mitsui Trust Holdings Inc. (4.91%), New York State Common Retirement Fund (1.94%), Conestoga Capital Advisors LLC (1.68%), Principal Financial Group Inc. (0.76%) and TimesSquare Capital Management LLC (0.58%). Company insiders that own Proto Labs stock include Arthur R Baker III, John B Goodman, John Way and Robert Bodor.
View institutional ownership trends for Proto Labs.

PRLB stock was sold by a variety of institutional investors in the last quarter, including TimesSquare Capital Management LLC, Conestoga Capital Advisors LLC, Summit Creek Advisors LLC, SG Americas Securities LLC, Russell Investments Group Ltd., Comerica Bank, US Bancorp DE, and Pembroke Management LTD.
View insider buying and selling activity for Proto Labs.

PRLB stock was acquired by a variety of institutional investors in the last quarter, including Sumitomo Mitsui Trust Holdings Inc., Premier Asset Management LLC, Riverbridge Partners LLC, TrimTabs Asset Management LLC, Sciencast Management LP, New York State Common Retirement Fund, Strs Ohio, and First Trust Advisors LP.
View insider buying and selling activity for Proto Labs.

Shares of PRLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PRLB stock can currently be purchased for approximately $130.13.

Proto Labs has a market capitalization of $3.48 billion and generates $458.73 million in revenue each year. The industrial products company earns $63.65 million in net income (profit) each year or $2.35 on an earnings per share basis. Proto Labs employs 2,535 workers across the globe.

The official website for Proto Labs is www.protolabs.com.

Proto Labs' mailing address is 5540 Pioneer Creek Drive, Maple Plain MN, 55359. The industrial products company can be reached via phone at 763-479-3680 or via email at [email protected]